Felicia L. Graham

4.2k total citations · 1 hit paper
43 papers, 3.2k citations indexed

About

Felicia L. Graham is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Felicia L. Graham has authored 43 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Felicia L. Graham's work include Virus-based gene therapy research (17 papers), Viral Infectious Diseases and Gene Expression in Insects (9 papers) and CAR-T cell therapy research (7 papers). Felicia L. Graham is often cited by papers focused on Virus-based gene therapy research (17 papers), Viral Infectious Diseases and Gene Expression in Insects (9 papers) and CAR-T cell therapy research (7 papers). Felicia L. Graham collaborates with scholars based in United States, Canada and United Kingdom. Felicia L. Graham's co-authors include L. Prevec, Andrew J. Bett, Wael Haddara, Jack Gauldie, Allison E. Ashley‐Koch, Christina Addison, Margaret A. Pericak‐Vance, Marilyn J. Telen, Jude Jonassaint and Laura M. De Castro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The EMBO Journal.

In The Last Decade

Felicia L. Graham

42 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

1994 636 citations Andrew J. Bett, L. Prevec et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Felicia L. Graham United States	27	1.5k	1.4k	576	449	392	43	3.2k
Colin G. Steward United Kingdom	37	1.6k 1.1×	762 0.6×	868 1.5×	881 2.0×	1.1k 2.7×	111	4.9k
Corry M.R. Weemaes Netherlands	36	3.2k 2.2×	964 0.7×	823 1.4×	947 2.1×	526 1.3×	111	4.9k
George Kannourakis Australia	27	1.2k 0.8×	1.1k 0.8×	1.3k 2.2×	1.6k 3.7×	258 0.7×	109	4.3k
Paul G. Rothberg United States	29	1.8k 1.2×	565 0.4×	836 1.5×	316 0.7×	317 0.8×	93	3.9k
Gerard J. te Meerman Netherlands	34	1.6k 1.1×	923 0.7×	559 1.0×	564 1.3×	386 1.0×	103	4.0k
Dwight A. Bellinger United States	35	2.4k 1.6×	2.6k 1.9×	1.2k 2.0×	349 0.8×	315 0.8×	81	4.7k
Christina Smith United States	32	1.5k 1.0×	388 0.3×	481 0.8×	382 0.9×	214 0.5×	80	3.3k
Françoise Selz France	20	1.7k 1.2×	1.5k 1.1×	743 1.3×	1.4k 3.2×	280 0.7×	32	3.5k
Sara Selig Israel	31	2.5k 1.7×	802 0.6×	119 0.2×	900 2.0×	294 0.8×	58	4.5k
HD Ochs United States	30	875 0.6×	616 0.5×	391 0.7×	2.0k 4.5×	529 1.3×	63	3.9k

Countries citing papers authored by Felicia L. Graham

Since Specialization

Citations

This map shows the geographic impact of Felicia L. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicia L. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicia L. Graham more than expected).

Fields of papers citing papers by Felicia L. Graham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felicia L. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicia L. Graham. The network helps show where Felicia L. Graham may publish in the future.

Co-authorship network of co-authors of Felicia L. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Felicia L. Graham. A scholar is included among the top collaborators of Felicia L. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felicia L. Graham. Felicia L. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Flynn, Kathryn E., Mary Amanda Dew, Li Lin, et al.. (2015). Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant. Quality of Life Research. 24(11). 2591–2599. 52 indexed citations

Reed, Shelby D., Matthew P. Neilson, Yanhong Li, et al.. (2015). Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure. American Heart Journal. 170(5). 951–960. 4 indexed citations

Dinan, Michaela A., Chia‐Hung Chou, Bradley G. Hammill, et al.. (2009). Outcomes of inpatients with and without sickle cell disease after high‐volume surgical procedures. American Journal of Hematology. 84(11). 703–709. 17 indexed citations

Reed, Shelby D., Y. Li, E.Z. Oddone, et al.. (2009). Economic Evaluation of Home Blood Pressure Monitoring With or Without Telephonic Behavioral Self-Management in Patients With Hypertension. American Journal of Hypertension. 23(2). 142–148. 46 indexed citations

Castro, Laura M. De, Jude Jonassaint, Felicia L. Graham, Allison E. Ashley‐Koch, & Marilyn J. Telen. (2007). Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes. American Journal of Hematology. 83(1). 19–25. 178 indexed citations

Hauser, Michael A., Dayse F Sena, Karen LaRocque-Abramson, et al.. (2006). Distribution of Optineurin Sequence Variations in an Ethnically Diverse Population of Low-tension Glaucoma Patients From the United States. Journal of Glaucoma. 15(5). 358–363. 64 indexed citations

Graham, Felicia L., David S. Enterline, John R. Gilbert, et al.. (2004). TERC is not a major gene in human neural tube defects. Birth Defects Research Part A Clinical and Molecular Teratology. 70(8). 531–533. 4 indexed citations

Castro, Laura M. De, Jude Jonassaint, Felicia L. Graham, Allison E. Ashley‐Koch, & Marilyn J. Telen. (2004). Pulmonary Hypertension in SS, SC and Sβ Thalassemia: Prevalence, Associated Clinical Syndromes, and Mortality.. Blood. 104(11). 1663–1663. 17 indexed citations

Allingham, R. Rand, et al.. (2003). Optineurin Sequence Variants Do Not Predispose to Primary Open Angle Glaucoma. Investigative Ophthalmology & Visual Science. 44(13). 3227–3227. 3 indexed citations

10.

Speer, Marcy C., Felicia L. Graham, Jeffrey M. Stajich, et al.. (2002). Reduction in the minimum candidate interval in the dominant-intermediate form of Charcot-Marie-Tooth neuropathy to D19S586 to D19S432. Neurogenetics. 4(2). 83–85. 7 indexed citations

11.

Winn, Michelle P., Peter J. Conlon, Kelvin L. Lynn, et al.. (1999). Linkage of a Gene Causing Familial Focal Segmental Glomerulosclerosis to Chromosome 11 and Further Evidence of Genetic Heterogeneity. Genomics. 58(2). 113–120. 97 indexed citations

12.

Winn, Michelle P., Peter J. Conlon, Kelvin L. Lynn, et al.. (1999). Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. Kidney International. 55(4). 1241–1246. 34 indexed citations

13.

Stewart, A. Keith, Norman J. Lassam, Ian Quirt, et al.. (1999). Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. Gene Therapy. 6(3). 350–363. 108 indexed citations

14.

Prince, H. Miles, Sophie Dessureault, Steven Gallinger, et al.. (1998). Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance.. PubMed. 26(1). 27–36. 25 indexed citations

15.

Lukacs, Nicholas W., Jack Gauldie, Felicia L. Graham, et al.. (1997). Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. The Journal of Immunology. 158(9). 4478–4484. 39 indexed citations

16.

Greenberger, M J, S L Kunkel, Robert M. Strieter, et al.. (1996). IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. The Journal of Immunology. 157(7). 3006–3012. 145 indexed citations

17.

Bett, Andrew J., L. Prevec, & Felicia L. Graham. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. Journal of Virology. 67(10). 5911–5921. 355 indexed citations

18.

Rowe, David, Philip E. Branton, & Felicia L. Graham. (1984). The Kinetics of Synthesis of Early Viral Proteins in KB Cells Infected with Wild-type and Transformation-defective Host-range Mutants of Human Adenovirus Type 5. Journal of General Virology. 65(3). 585–597. 23 indexed citations

19.

Graham, Felicia L.. (1984). Covalently closed circles of human adenovirus DNA are infectious.. The EMBO Journal. 3(12). 2917–2922. 83 indexed citations

20.

Graham, Felicia L.. (1977). Biological Activity of Tumor Virus Dna. Advances in cancer research. 1–51. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact